A comparative analysis of major clinical outcomes using drug-eluting stents versus bare metal stents in diabetic versus nondiabetic patients

Catheterization and Cardiovascular Interventions

Volumn 78, Issue 5, 2011, Pages 710-717

  Minha, Sa'Ar ^a,b   Bental, Tamir ^b,c   Assali, Abid ^b,c   Vaknin Assa, Hana ^b,c   Lev, Eli I ^b,c   Rechavia, Eldad ^b,c   Battler, Alexander ^b,c   Kornowski, Ran ^b,c  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c RABIN MEDICAL CENTER   (Israel)

Author keywords

coronary artery disease; diabetes mellitus; drug eluting stent; percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ADULT; AGED; ARTICLE; BARE METAL STENT; CARDIOVASCULAR RISK; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE REGISTRY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HAZARD RATIO; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; REVASCULARIZATION; RISK ASSESSMENT; SURVIVAL;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY DISEASE; DIABETES COMPLICATIONS; DISEASE-FREE SURVIVAL; DRUG-ELUTING STENTS; FEMALE; HUMANS; ISRAEL; LIFE TABLES; MALE; METALS; MYOCARDIAL INFARCTION; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; PROSTHESIS DESIGN; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; STENTS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 80054966954     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.23062     Document Type: Article

References (25)

1. Luscher TF, Creager MA, Beckman JA, Cosentino F,. Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part II. Circulation 2003; 108: 1655-1661. (Pubitemid 37187795)
2. Abizaid A, Kornowski R, Mintz GS, Hong MK, Abizaid AS, Mehran R, Pichard AD, Kent KM, Satler LF, Wu H, et al. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol 1998; 32: 584-589. (Pubitemid 28435240)
3. Iijima R, Ndrepepa G, Mehilli J, Markwardt C, Bruskina O, Pache J, Ibrahim M, Schomig A, Kastrati A,. Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era. Am Heart J 2007; 154: 688-693. (Pubitemid 47440084)
4. Cutlip DE, Chhabra AG, Baim DS, Chauhan MS, Marulkar S, Massaro J, Bakhai A, Cohen DJ, Kuntz RE, Ho KKL,. Beyond restenosis: Five-year clinical outcomes from second-generation coronary stent trials. Circulation 2004; 110: 1226-1230. (Pubitemid 39202337)
5. Kirtane AJ, Ellis SG, Dawkins KD, Colombo A, Grube E, Popma JJ, Fahy M, Leon MB, Moses JW, Mehran R, et al. Paclitaxel-eluting coronary stents in patients with diabetes mellitus: Pooled analysis from 5 randomized trials. J Am Coll Cardiol 2008; 51: 708-715. (Pubitemid 351227416)
6. Kastrati A, Mehilli J, Pache J, Kaiser C, Valgimigli M, Kelbæk H, Menichelli M, Sabaté M, Suttorp MJ, Baumgart D, et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2009; 356: 1030-1039. (Pubitemid 46376803)
7. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-1323. (Pubitemid 37186209)
8. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004; 350: 221-231. (Pubitemid 38067635)
9. Bental T, Assali A, Vaknin-Assa H, Lev EI, Brosh D, Fuchs S, Battler A, Kornowski R,. A comparative analysis of major clinical outcomes using drug-eluting stents versus bare-metal stents in a large consecutive patient cohort. Catheter Cardiovasc Interv 2010; 76: 374-380.
10. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004; 27 (Suppl 1): S5-S10.
11. Sabate M, Jimenez-Quevedo P, Angiolillo DJ, Gomez-Hospital JA, Alfonso F, Hernandez-Antolin R, Goicolea J, Banuelos C, Escaned J, Moreno R, et al. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: The diabetes and sirolimus-eluting stent (DIABETES) trial. Circulation 2005; 112: 2175-2183. (Pubitemid 41475813)
12. Moussa I, Leon MB, Baim DS, O'Neill WW, Popma JJ, Buchbinder M, Midwall J, Simonton CA, Keim E, Wang P, et al. Impact of sirolimus-eluting stents on outcome in diabetic patients: A SIRIUS (SIRolImUS-coated Bx velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy. Circulation 2004; 109: 2273-2278. (Pubitemid 38678518)
13. Dibra A, Kastrati A, Mehilli J, Pache J, Schuhlen H, von Beckerath N, Ulm K, Wessely R, Dirschinger J, Schomig A,. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med 2005; 353: 663-670. (Pubitemid 41175674)
14. Stettler C, Allemann S, Egger M, Windecker S, Meier B, Diem P,. Efficacy of drug eluting stents in patients with and without diabetes mellitus: Indirect comparison of controlled trials. Heart 2006; 92: 650-657.
15. Patti G, Nusca A, Di Sciascio G,. Meta-analysis comparison (nine trials) of outcomes with drug-eluting stents versus bare metal stents in patients with diabetes mellitus. Am J Cardiol 2008; 102: 1328-1334.
16. Mahmud E, Bromberg-Marin G, Palakodeti V, Ang L, Creanga D, Demaria AN,. Clinical efficacy of drug-eluting stents in diabetic patients: A meta-analysis. J Am Coll Cardiol 2008; 51: 2385-2395. (Pubitemid 351815166)
17. Ortolani P, Balducelli M, Marzaroli P, Piovaccari G, Menozzi A, Guiducci V, Sangiorgio P, Tarantino F, Geraci G, Castriota F, et al. Two-year clinical outcomes with drug-eluting stents for diabetic patients with de novo coronary lesions: Results from a real-world multicenter registry. Circulation 2008; 117: 923-930. (Pubitemid 351272590)
18. Dominguez Franco AJ, Alonso Briales JH, Jimenez Navarro MF, Hernandez Garcia JM, Garcia Pinilla JM, Perez Caravante M, de Teresa Galvan E,. Clinical impact of drug-eluting stents in an unselected population of diabetic patients. Clin Cardiol 2008; 31: 165-171. (Pubitemid 351556482)
19. Stenestrand U, James SK, Lindback J, Frobert O, Carlsson J, Schersten F, Nilsson T, Lagerqvist B,. Safety and efficacy of drug-eluting vs. bare metal stents in patients with diabetes mellitus: Long-term follow-up in the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Eur Heart J 2010; 31: 177-186.
20. Ramanath VS, Brown JR, Malenka DJ, DeVries JT, Sidhu MS, Robb JF, Jayne JE, Hettleman BD, Friedman BJ, Niles NW II, et al. Outcomes of diabetics receiving bare-metal stents versus drug-eluting stents. Catheter Cardiovasc Interv 2010; 76: 473-481.
21. Garg P, Normand SL, Silbaugh TS, Wolf RE, Zelevinsky K, Lovett A, Varma MR, Zhou Z, Mauri L,. Drug-eluting or bare-metal stenting in patients with diabetes mellitus: Results from the Massachusetts Data Analysis Center Registry. Circulation 2008; 118: 2277-2285.
22. Elezi S, Kastrati A, Pache J, Wehinger A, Hadamitzky M, Dirschinger J, Neumann FJ, Schomig A,. Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. J Am Coll Cardiol 1998; 32: 1866-1873. (Pubitemid 29010448)
23. Mak KH, Faxon DP,. Clinical studies on coronary revascularization in patients with type 2 diabetes. Eur Heart J 2003; 24: 1087-1103. (Pubitemid 36723574)
24. Aronson D, Edelman ER,. Revascularization for coronary artery disease in diabetes mellitus: Angioplasty, stents and coronary artery bypass grafting. Rev Endocr Metab Disord 2010; 11: 75-86.
25. Kirtane A, Gupta A, Iyengar S, Moses J, Leon M, Applegate R, Brodie B, Hannan E, Harjai K, Jensen L, et al. Safety and efficacy of drug-eluting and bare metal stents: Comprehensive meta-analysis of randomized trials and observational studies. Circulation 2009; 119: 3198-3206.